RecallRadar

FDA Drug recall D-0605-2021

DELFLEX Peritoneal Dialysis Solution with 2.5 % Dextrose, Low Magnesium, Low Calcium, packaged in a) 3000 mL 2 packs (NDC 49230-0209-23), b…

On 2021-06-16 the FDA classified a Class III recall of DELFLEX Peritoneal Dialysis Solution with 2.5 % Dextrose, Low Magnesium, Low Calcium, packaged in a) 3000 mL 2 packs (NDC 49230-0209-23), b… by Fresenius Medical Care Holdings, citing temperature Abuse: Product exposed to temperature outside specified limits.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0605-2021
ClassificationClass III
Statusterminated
Initiated2021-04-28
Published2021-06-16
Last updated2026-09-13 11:52 UTC
CompanyFresenius Medical Care Holdings
DistributionUS

Product

DELFLEX Peritoneal Dialysis Solution with 2.5 % Dextrose, Low Magnesium, Low Calcium, packaged in a) 3000 mL 2 packs (NDC 49230-0209-23), b) 3000 mL (NDC 49230-209-30) and c) 5000 mL (NDC 49230-209-50) Rx only, Fresenius Medical Care NA Waltham, MA 02451

Reason

Temperature Abuse: Product exposed to temperature outside specified limits.

Identifiers

ndc49230-206-30
ndc49230-206-32
ndc49230-206-50
ndc49230-206-52
ndc49230-206-62
ndc49230-209-30
ndc49230-209-32
ndc49230-209-50
ndc49230-209-52
ndc49230-209-62
ndc49230-212-30
ndc49230-212-32
ndc49230-212-50
ndc49230-212-52
ndc49230-212-62
ndc49230-0209-23
code_info
Lot #: a) 20PU03043, Exp. Date June 2022; b) 20SU03036, Exp. date July 2022; c) 20Su07012, Exp. date July 2022; 21AU070…Lot #: a) 20PU03043, Exp. Date June 2022; b) 20SU03036, Exp. date July 2022; c) 20Su07012, Exp. date July 2022; 21AU07021, 21AU02037, 21AU01007, 21AU01006, 21AU01019, Exp. date August 2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0605-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.